Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides

IGF-1 LR3

Growth Hormone
Phase 1 Research
35%
Moderate Risk
3/5

Dosing Protocol

Typical Dose 50 mcg
Range 20 - 100 mcg
Maintenance 50 mcg daily
Cycle 4w on / 4w off

Pharmacokinetics

Half-Life 1.0 days
Onset 1.0 hrs
Peak 3.0 hrs
Duration 1.0 days
Bioavailability 90%
Primary Route Subcutaneous

Administration

Routes Subcutaneous, Intramuscular
Injection Sites Abdomen, Target Muscle
Needle Gauge 29-31G
Syringe Type Insulin
Timing Post-Workout, Morning

Reconstitution

Diluent Bacteriostatic Water
Volume 1 mL
Concentration 1000 mcg/mL
Stability 21 days refrigerated
Vial Sizes 1 mg

Special Instructions

Site-specific injections common for localized muscle growth. 3x more potent than native IGF-1. Use immediately after workout for best results.